diclofenac has been researched along with pentoxifylline in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bohácek, J; Hofer, M; Pipalová, I; Pospísil, M; Sandula, J | 1 |
| Dommerich, S; Graumüller, S; Hoff, M; Ostwald, J | 1 |
| Chappell, AS; D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Smith, TR; Wang, F; Wernicke, JF | 1 |
| Al-Gareeb, AI; Al-Kuraishy, HM; Hussien, NR | 1 |
| Abdel-Razek, NS; Salem, HA; Wadie, W | 1 |
| De Giorgio, G; Paulis, G | 2 |
| Al-Gareeb, AI; Al-Kuraishy, HM; Alorabi, M; Batiha, GE; Cavalu, S; El-Kadem, AH; Mostafa-Hedeab, G; Negm, WA; Saad, HM; Youssef, A | 1 |
1 review(s) available for diclofenac and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for diclofenac and pentoxifylline
| Article | Year |
|---|---|
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Topics: Acetaminophen; Amitriptyline; Analgesics; Carbamazepine; Diabetes Complications; Diabetic Neuropathies; Diclofenac; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Lipids; Male; Meloxicam; Middle Aged; Neuralgia; Pentoxifylline; Selective Serotonin Reuptake Inhibitors; Thiamine; Thiazines; Thiazoles; Thioctic Acid; Thiophenes; Time; Vitamin B 12 | 2007 |
11 other study(ies) available for diclofenac and pentoxifylline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Enhancement by carboxymethylglucan of early cellular damage in 1 Gy-irradiated mice.
Topics: Animals; beta-Glucans; Cell Death; Cells; Diclofenac; Gamma Rays; Glucans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Pentoxifylline; Radiation-Sensitizing Agents; Thymidine; Time Factors; Whole-Body Irradiation | 1995 |
[Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Androstadienes; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Beclomethasone; Calcium Channel Blockers; Cells, Cultured; Culture Media; Diclofenac; Fibroblasts; Fluticasone; Glucocorticoids; Hematologic Agents; Humans; In Vitro Techniques; Mesalamine; Methylprednisolone; Mometasone Furoate; Muscarinic Agonists; Nasal Polyps; Pentoxifylline; Pilocarpine; Piroxicam; Prednisolone; Pregnadienediols; Time Factors; Timolol; Verapamil | 2003 |
Berberine and Pentoxifylline: A novel combination in amelioration of acute kidney injury.
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Berberine; Biomarkers; Creatinine; Cystatin C; Diclofenac; Drug Therapy, Combination; Free Radical Scavengers; Lipocalins; Male; Pentoxifylline; Rats; Rats, Sprague-Dawley | 2019 |
Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Cilostazol; Creatinine; Diclofenac; Kidney; Male; NF-kappa B; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Wistar; Sildenafil Citrate; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2021 |
Complete Plaque Regression in Patients with Peyronie's Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases.
Topics: Antioxidants; Combined Modality Therapy; Diclofenac; Humans; Male; Middle Aged; Pain; Penile Induration; Pentoxifylline | 2022 |
Pentoxifylline and berberine mitigate diclofenac-induced acute nephrotoxicity in male rats via modulation of inflammation and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Glutathione; Inflammation; Kidney; Lipocalin-2; Male; Oxidative Stress; Pentoxifylline; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Superoxide Dismutase | 2022 |
Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.
Topics: Adult; Antioxidants; Combined Modality Therapy; Diclofenac; Humans; Male; Middle Aged; Pain; Penile Induration; Penis; Pentoxifylline; Skin Abnormalities | 2022 |